Table 3 Frequencies of promoter methylation which differ significantly between ovarian clear cell adnocarcinoma and non-OCCA tissues
From: Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
| Â | Percentage (case number/total) | Â | |
|---|---|---|---|
Gene name | Clear cell | Non-clear cell | p value |
| Â | (n=47) | (n=63) | Â |
RASS328 | 72% (34) | 16% (10) | <0.001 |
RASS382 | 77% (36) | 17% (11) | <0.001 |
ESR1 | 9% (4) | 0% (0) | 0.018 |
CDKN2B | 28% (13) | 5% (3) | 0.001 |
CDKN1B | 6% (3) | 0% (0) | 0.042 |
CDH13 | 47% (22) | 11% (7) | <0.001 |
BRCA1 | 0% (0) | 17% (11) | 0.002 |
SCG148 | 40% (19) | 8% (5) | 0.001 |
ID4346 | 19% (9) | 5% (3) | 0.016 |
SFRP382 | 11% (5) | 0% (0) | 0.008 |
SFRP5211 | 23% (14) | 6% (4) | 0.01 |
CACNA1A | 43% (20) | 11% (7) | <0.001 |